SOURCE: Eurand N.V.

Eurand N.V.

September 02, 2010 10:42 ET

Eurand to Participate in Upcoming Investor Conferences

PHILADELPHIA, PA--(Marketwire - September 2, 2010) -  Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate in the following upcoming investor conferences:

Event: Stifel Nicolaus Healthcare Conference
Date: Thursday, September 16, 2010
Time: 10:20 a.m. ET
Location: Four Seasons Hotel
  200 Boylston Street
  Boston, Mass.
Speaker: Gearóid Faherty, Chairman and Chief Executive Officer
Event: UBS Global Life Sciences Conference
Date: Monday, September 20, 2010
Time: 9:00 a.m. ET
Location: Grand Hyatt Hotel
  Park Avenue at Grand Central
  New York, N.Y.
Speaker: John Fraher, Chief Commercial Officer

An audio webcast of the Company's presentations at each conference will be available by accessing the investor relations section of and will be available via replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit

Contact Information

  • Contacts:
    Bill Newbould
    Vice President, Investor Relations
    Eurand N.V.
    Email Contact

    Nick Laudico/Sara Pellegrino
    The Ruth Group
    Email Contact
    Email Contact